Article Details
Retrieved on: 2022-05-16 11:38:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Baili-Biopharmaceutical and AstraZeneca have signed a trial partnership and supply agreement for SI-B001 plus Tagrisso to treat NSCLC.
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here